EU Ups Funding For Pandemic R&D, Parliament Backs ‘Strategic Autonomy’ In Medical Product Development

With the latest round of discussions on a proposed global pandemic treaty starting this week, one law firm explains how the treaty’s plans for pathogen access and benefit sharing will directly affect many companies developing pandemic products.

3d rendering Virus bacteria cells background — Infectious diseases pose a constant threat • Source: Shutterstock

The World Health Organization may well have announced the end of the emergency phase of the COVID-19 pandemic, and there has been a more or less steady decline in cases at global level, but the virus is still taking its toll.

More than 794,000 new cases and more than 4,800 deaths were reported in the period from 12 June to 9...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

‘UK Must Put Adoption On A Par With Innovation’

12 Jun 2025

• By Ashley Yeo

Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.

Sofinnova And NVIDIA Partner To ‘Supercharge’ Computation For European Startups

12 Jun 2025

• By Natasha Barrow

European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.

Medtechs Wait For Dividend As UK Spending Review Prioritizes Healthcare And NHS

11 Jun 2025

• By Ashley Yeo

Increased support for NHS services and delivery infrastructure announced in the 11 June government spending review by chancellor of the exchequer Rachel Reeves could boost inward investment and offer new market opportunities for medtechs.

UK Healthtech Center Of Excellence Given Key MHRA Digital Regulation Role

11 Jun 2025

• By Ashley Yeo

Ahead of the 11 June UK spending review and its anticipated funding uplift for healthcare and life sciences, the MHRA announced an expansion of its digital expertise by creating a dedicated hub in Leeds, a renowned center of medtech excellence.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

11 Jun 2025

• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.